chr4-108027757-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005327.7(HADH):c.706C>T(p.Arg236*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000692 in 1,589,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005327.7 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HADH | NM_005327.7 | c.706C>T | p.Arg236* | stop_gained | 6/8 | ENST00000309522.8 | NP_005318.6 | |
HADH | NM_001184705.4 | c.706C>T | p.Arg236* | stop_gained | 6/9 | NP_001171634.3 | ||
HADH | NM_001331027.2 | c.718C>T | p.Arg240* | stop_gained | 6/8 | NP_001317956.2 | ||
HADH | XR_007096395.1 | n.750C>T | non_coding_transcript_exon_variant | 6/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HADH | ENST00000309522.8 | c.706C>T | p.Arg236* | stop_gained | 6/8 | 1 | NM_005327.7 | ENSP00000312288.4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251328Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135840
GnomAD4 exome AF: 0.00000626 AC: 9AN: 1437560Hom.: 0 Cov.: 26 AF XY: 0.00000698 AC XY: 5AN XY: 716796
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152062Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74284
ClinVar
Submissions by phenotype
Deficiency of 3-hydroxyacyl-CoA dehydrogenase Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2023 | This sequence change creates a premature translational stop signal (p.Arg236*) in the HADH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HADH are known to be pathogenic (PMID: 8825408). This variant is present in population databases (rs375717077, gnomAD 0.008%). This premature translational stop signal has been observed in individual(s) with clinical features of medium/short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (PMID: 19318379, 24686051). ClinVar contains an entry for this variant (Variation ID: 39482). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jun 03, 2023 | - - |
Hyperinsulinemic hypoglycemia, familial, 4 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Nov 02, 2021 | The p.Arg236Ter variant in HADH has been reported in at least 7 individuals with familial hyperinsulinemic hypoglycemia (PMID: 21252247, 19318379), segregated with disease in 2 affected relatives from 1 family (Çayır et al., abstract), and has been identified in 0.008% (2/24952) of African/African American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs375717077). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 39482) and has been interpreted as pathogenic by OMIM. This nonsense variant leads to a premature termination codon at position 236, which is predicted to lead to a truncated or absent protein. Loss of function of the HADH gene is strongly associated to autosomal recessive familial hyperinsulinemic hypoglycemia. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for familial hyperinsulinemic hypoglycemia. ACMG/AMP Criteria applied: PVS1_strong, PM2_supporting, PM3, PP1 (Richards 2015). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2011 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 26, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at